Form 4: IperionX Director Todd Hannigan Buys 225,225 Shares

Director Todd Hannigan purchased 225,225 ordinary shares at A$3.2009 and disclosed substantial existing holdings, RSUs, and long‑dated performance rights.

Summary

• On 03/27/2026, Director Todd Hannigan purchased 225,225 ordinary shares on the ASX at an average price of A$3.2009 per share.
• Following the transaction, he beneficially owns 25,628,334 ordinary shares (direct).
• He also directly owns 50,000 American Depositary Shares (ADS) on Nasdaq, equivalent to 500,000 ordinary shares (1 ADS = 10 ordinary shares).
• Equity awards include 454,464 RSUs: 159,334 vest in December 2026 and 295,130 in April 2028.
• Derivative holdings comprise performance rights for 306,302 underlying ordinary shares at each of A$6, A$7, and A$8, exercisable 04/10/2029 and expiring 04/10/2030 (total 918,906 underlying shares).
• The Form 4 was signed on 03/30/2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive insider-sentiment event driven by a sizable open‑market purchase and substantial equity alignment, partially offset by potential future dilution from RSUs and performance rights.

Positives

• Increased insider ownership via open‑market purchase of 225,225 ordinary shares at A$3.2009 (~A$720.9k).
• Large direct stake after the trade: 25,628,334 ordinary shares plus 50,000 ADS (equivalent to 500,000 ordinary shares).
• Significant long‑term equity incentives (454,464 RSUs and 918,906 performance rights) align management interests with shareholders.

Negatives

• Potential future dilution from 454,464 RSUs and up to 918,906 performance rights if vesting and exercise conditions are met between 2026–2030.

Future Outlook

NA

Industry Context

StockSavvy.ai notes insider open‑market purchases are typically viewed as a constructive signal across materials and industrials, particularly when paired with sizable ongoing equity alignment; however, such transactions do not convey operational guidance.

Comparison to Industry Standards

• Relative to U.S.-listed metals/materials peers (e.g., MP Materials, ATI, Alcoa), open‑market insider purchases of approximately A$0.7m are considered meaningful and less common than routine equity grants.
• The long‑dated 2029–2030 exercise window for performance rights is longer than the typical 3–4 year vesting horizon seen across many industrials and materials companies, indicating a long‑term incentive focus.
• The mix of ASX‑traded ordinary shares and Nasdaq‑traded ADS, alongside RSUs and performance rights, is broadly consistent with cross‑listed issuers balancing global investor participation.

Stakeholder Impact

• Shareholders may view the director’s ~A$720.9k open‑market purchase as a vote of confidence.
• Potential issuance of up to 1,373,370 ordinary shares from RSUs and performance rights could dilute existing holders if vesting and exercise conditions are met.
• Dual‑traded structure (ASX ordinary shares and Nasdaq ADS) provides multiple trading venues that can affect liquidity preferences among investors.

Next Steps

• Monitor RSU vesting in December 2026 and April 2028.
• Track performance rights exercisability beginning 04/10/2029 and expiration on 04/10/2030.

Key Dates

Recommendation

The open‑market insider purchase is a constructive signal, but without operational or financial updates in this filing, a prudent stance is to hold while monitoring subsequent corporate disclosures and the vesting/exercise timelines of equity awards.

Keywords

IperionX, IPX, Todd Hannigan, Form 4, insider purchase, ordinary shares, ADS, RSU, performance rights, ASX, Nasdaq, beneficial ownership